Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he has taken with Cabinet colleagues to implement recommendation nine of the Infected Blood Inquiry's report.

It is crucial we protect the safety of haemophilia care and the Government is committed to implementing recommendation 9 of the 2024 Infected Blood Inquiry report.

The Government is committed to improving the lives of those living with rare diseases, such as haemophilia. The UK Rare Diseases Framework sets out four priorities collaboratively developed with the rare disease community: these include getting a final diagnosis faster; increasing awareness of rare diseases among healthcare professionals; better coordination of care; and improving access to specialist care, treatments, and drugs. We published the fifth annual England action plan in February 2026, where we report on the steps we have taken to advance these priorities.

This includes peer review of UK comprehensive care centres, which has been an essential part of haemophilia services for many years. The triennial audit was replaced in 2019 with a more formal peer review process on a five-year cycle.

The final peer review report is expected to be published imminently and once published, will be shared with the NHSE Specialised Commissioning Quality Oversight Group for consideration and action. This will be supported by a letter to Integrated Care Boards and Trust Boards, emphasising the valuable role of peer review and ask for confirmation of their commitment to review and implement the peer review findings.

The Haemophilia Service Specification has been updated by the Blood Disorders Clinical Reference Group and is making its way through final approvals, having undergone public consultation. The new specification includes a contractual requirement for providers to participate in, and act upon peer review findings.